The first half of Tibet's pharmaceutical industry net profit 4.25 million Yuan fell 31%

NetEase Finance July 27 News Tibet Pharmaceutical Industry released 2010.5 Annual report in Shanghai in Tuesday evening. In the first half of 2010, the Tibetan pharmaceutical industry realized operating income of 553 million yuan, an increase of 3.34%, the total profit of 6.3301 million yuan, down 10.44%, the net profit of the listed company shareholders 4.2513 million yuan, down 31.17%　　Basic earnings per share of 0.031 yuan, down 31.11% year-on-year. The Half-year report showed that in the first half of 2010, the operating cost of Tibet pharmaceutical industry 462 million yuan, an increase of 2.64%, the cost increase is less than the income growth. The Tibetan pharmaceutical industry said it was mainly due to changes in sales composition.　　In fact, due to the increase in raw material and labor costs, the cost of their own products increased by 2.58% over a year earlier; other goods sales cost rate increased by 1.94% profit distribution plan: Tibet Pharmaceutical Industry said that in the middle of 2010, the company does not carry out Capital Provident Fund to increase equity, nor cash dividends. Related topics: Semi-annual report of 2010 listed Companies